Stocks and Investing
Stocks and Investing
Wed, April 24, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, April 23, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joseph Pantginis Maintained (ATXS) at Strong Buy with Decreased Target to $16 on, Apr 23rd, 2024
Joseph Pantginis of HC Wainwright & Co., Maintained "Astria Therapeutics, Inc." (ATXS) at Strong Buy with Decreased Target from $18 to $16 on, Apr 23rd, 2024.
Joseph has made no other calls on ATXS in the last 4 months.
There are 3 other peers that have a rating on ATXS. Out of the 3 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joseph
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $29 on, Tuesday, March 26th, 2024
- Laura Chico of "Wedbush" Maintained at Buy and Held Target at $17 on, Tuesday, March 26th, 2024
- Eun Yang of "Jefferies" Maintained at Strong Buy with Increased Target to $27 on, Monday, March 25th, 2024
Contributing Sources